dc.contributor.author | Etievant, Sibyle et al. | |
dc.date.accessioned | 2020-05-18T18:57:07Z | |
dc.date.available | 2020-05-18T18:57:07Z | |
dc.date.issued | 2020-05-04 | |
dc.identifier.uri | https://doi.org/10.1101/2020.05.03.20072207 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/1540 | |
dc.description.abstract | The sensitivity of SARS-CoV-2 RT-PCR tests developed by Charite (Germany), HKU (Hong-Kong), China CDC (China), US CDC (United-States), and Institut Pasteur, Paris (France) was assessed on SARS-CoV-2 cell culture supernatants and clinical samples. Although all RT-PCR assays performed well for SARS-CoV-2 detection, RdRp Institut Pasteur (IP2, IP4), N China CDC, and N1 US CDC were found to be the most sensitive. | en_US |
dc.language | English | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Infectious Diseases | en_US |
dc.subject | SARS-CoV | en_US |
dc.subject | Cell Culture Techniques | en_US |
dc.subject | Polymerase Chain Reaction | en_US |
dc.title | Sensitivity assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories | en_US |
eihealth.country | Regional, Americas (PAHO/OPS) | en_US |
eihealth.category | Virus: natural history, transmission and diagnostics | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Slow Spread / Reducir la Dispersión | en_US |
dc.relation.ispartofjournal | medRxiv | en_US |